Testing effectiveness (Phase 2)Study completedNCT05694819
What this trial is testing
Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY)
Who this might be right for
Salivary Gland Cancer
National Cancer Center Hospital East 57